PARAMETRIC PORTFOLIO ASSOCIATES LLC - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$35,666,000
+57.0%
1,534,677
+7.6%
0.03%
+54.5%
Q1 2018$22,712,000
-15.3%
1,426,661
+10.6%
0.02%
-18.5%
Q4 2017$26,807,000
+90.7%
1,290,027
+31.5%
0.03%
+80.0%
Q3 2017$14,057,000
+0.6%
980,919
+21.5%
0.02%
-11.8%
Q2 2017$13,967,000
+204.8%
807,319
+94.3%
0.02%
+142.9%
Q1 2017$4,582,000
+59.2%
415,402
+109.6%
0.01%
+75.0%
Q4 2016$2,878,000
-5.6%
198,224
+59.6%
0.00%
-20.0%
Q3 2016$3,048,000
+291.8%
124,173
+221.5%
0.01%
+400.0%
Q2 2016$778,000
-94.8%
38,620
-93.2%
0.00%
-95.8%
Q1 2016$14,832,000
-70.3%
563,955
+14.8%
0.02%
-71.8%
Q4 2015$49,923,000
-38.7%
491,125
+7.5%
0.08%
-46.5%
Q3 2015$81,471,000
+129.1%
456,727
+185.3%
0.16%
+130.4%
Q2 2015$35,565,000
+13.9%
160,095
+1.9%
0.07%
+9.5%
Q1 2015$31,217,000
+202.9%
157,170
+118.2%
0.06%
+186.4%
Q4 2014$10,306,000
-17.0%
72,015
-23.9%
0.02%
-18.5%
Q3 2014$12,413,000
+40.1%
94,613
+34.7%
0.03%
+35.0%
Q2 2014$8,859,000
+24.2%
70,243
+29.8%
0.02%
+17.6%
Q1 2014$7,132,000
+11.6%
54,099
-0.6%
0.02%
+13.3%
Q4 2013$6,391,000
+2.7%
54,439
-8.8%
0.02%
-11.8%
Q3 2013$6,226,000
+19.1%
59,676
-1.7%
0.02%
+13.3%
Q2 2013$5,226,00060,7130.02%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q1 2018
NameSharesValueWeighting ↓
Chou Associates Management 1,648,992$38,323,00014.52%
Paulson & Co. 20,839,035$484,299,0009.89%
MILLER VALUE PARTNERS, LLC 4,999,064$116,178,0004.34%
GoldenTree Asset Management 1,140,205$26,498,0004.21%
Pomelo Capital LLC 1,760,000$40,902,0004.00%
Bruce & Co., Inc. 860,000$19,986,0003.98%
ValueAct Holdings 18,033,149$419,090,0003.79%
Stanley Capital Management, LLC 318,400$7,400,0003.25%
Kazazian Asset Management, LLC 134,784$3,132,0002.87%
Phoenix Investment Adviser LLC 58,400$1,357,0002.48%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders